v3.25.2
Cash and Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Cash and Cash Equivalents and Marketable Securities

3. Cash and Cash Equivalents and Marketable Securities

Cash and cash equivalents and marketable securities were comprised of the following:

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

As of June 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 Cash

 

$

16,195

 

 

$

 

 

$

 

 

$

16,195

 

 Money market funds

 

 

48,468

 

 

 

 

 

 

 

 

 

48,468

 

 Commercial paper

 

 

2,993

 

 

 

 

 

 

 

 

 

2,993

 

 Total cash and cash equivalents:

 

$

67,656

 

 

$

 

 

$

 

 

$

67,656

 

 Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 Commercial paper

 

 

41,824

 

 

 

 

 

 

(8

)

 

 

41,816

 

 Total marketable securities

 

$

41,824

 

 

$

 

 

$

(8

)

 

$

41,816

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 Cash

 

$

43,762

 

 

$

 

 

$

 

 

$

43,762

 

 Money market funds

 

 

25,522

 

 

 

 

 

 

 

 

 

25,522

 

 Commercial paper

 

 

15,430

 

 

 

3

 

 

 

 

 

 

15,433

 

 Total cash and cash equivalents:

 

$

84,714

 

 

$

3

 

 

$

 

 

$

84,717

 

 Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 U.S. Treasury and government-sponsored
   enterprises

 

$

3,013

 

 

$

1

 

 

$

 

 

$

3,014

 

 Commercial paper

 

 

40,688

 

 

 

39

 

 

 

(1

)

 

 

40,726

 

 Corporate debt securities

 

 

24,322

 

 

 

13

 

 

 

(1

)

 

 

24,334

 

 Total marketable securities

 

$

68,023

 

 

$

53

 

 

$

(2

)

 

$

68,074

 

 

Interest receivable was $0.2 million and $0.4 million as of June 30, 2025 and December 31, 2024, respectively, and is included in other current receivables.

Available-for-sale marketable securities with an aggregate fair value of $33.7 million and $7.8 million as of June 30, 2025 and December 31, 2024, respectively, were held in an immaterial, unrealized loss position. These marketable securities have been in an unrealized loss position for less than twelve months. The unrealized losses were not attributed to credit risk but were primarily associated with changes in interest rates and market liquidity. The Company does not intend to sell these securities and it is more likely than not that it will hold these investments for a period of time sufficient to recover the amortized cost. As a result, the Company did not record an allowance for credit losses or other impairment charges for its marketable securities for the six months ended June 30, 2025 and 2024.

The Company recognized nil of net unrealized loss in other comprehensive loss in the three months ended June 30, 2025 and 2024, respectively, and a net unrealized loss of $0.1 million and $0.2 million in the six months ended June 30, 2025 and 2024, respectively, in relation to its cash and cash equivalents and marketable securities.

The maturities of the Company’s marketable securities as of June 30, 2025 and December 31, 2024 are less than one year.